Key result
This narrative review provides a broad overview of the composition, pharmacological mechanisms, and clinical applications of Tongxinluo capsules for cardiovascular disease.
Why the study?
Cardiovascular disease remains the leading cause of death with suboptimal outcomes, and awareness of Tongxinluo capsules remains limited in the United States.
This narrative review highlights the composition, mechanisms, and clinical applications of Tongxinluo capsules as an alternative treatment for cardiovascular disease.
Cardiovascular disease (CVD) has remained the leading cause of death among adults for more than one hundred years. With persistently suboptimal outcomes and a profound economic burden on our healthcare system, there is growing interest in alternative treatment approaches for CVD. One such approach is Tongxinluo (TXL) capsules, a Traditional Chinese Medicine (TCM). TXL is commonly used in China and offers a potentially safe, efficacious, and cost-effective treatment option. To address the limited awareness of TXL in the United States, this narrative review will provide a broad overview of its composition, pharmacological mechanisms, and clinical applications.
No takes yet. Share an insight, caveat, or question.
Barris et al. (2025) conducted a review in Cardiovascular disease. Tongxinluo (TXL) capsules was evaluated. This narrative review provides a broad overview of the composition, pharmacological mechanisms, and clinical applications of Tongxinluo capsules for cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: